Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy
about
MicroRNAs in the Stressed Heart: Sorting the Signal from the NoiseDecreased polycystin 2 expression alters calcium-contraction coupling and changes β-adrenergic signaling pathways.Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506.RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis.Differential expression of microRNAs in ischemic heart disease.The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca²⁺-release channel.Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 PhosphorylationThree-Directional Evaluation of Mitral Flow in the Rat Heart by Phase-Contrast Cardiovascular Magnetic Resonance.Characterization and Functional Analysis of Extracellular Vesicles and Muscle-Abundant miRNAs (miR-1, miR-133a, and miR-206) in C2C12 Myocytes and mdx MiceHDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs.Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis.The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophyCalcineurin-NFATc regulates type 2 inositol 1,4,5-trisphosphate receptor (InsP3R2) expression during cardiac remodeling.Identifying potential functional impact of mutations and polymorphisms: linking heart failure, increased risk of arrhythmias and sudden cardiac deathMicroRNAs meet calcium: joint venture in ER proteostasis.microRNA-133a attenuates cardiomyocyte hypertrophy by targeting PKCδ and Gq.Cardiomyocyte Ca2+ dynamics: clinical perspectives.Vitamin D, reactive oxygen species and calcium signalling in ageing and disease.miR-133a mediates the hypoxia-induced apoptosis by inhibiting TAGLN2 expression in cardiac myocytes.Determining the Roles of Inositol Trisphosphate Receptors in Neurodegeneration: Interdisciplinary Perspectives on a Complex Topic.IP3 receptor mutations and brain diseases in human and rodents.Mitochondrial calcium uniporter, MiRNA and cancer: Live and let die.Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors.Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice.Inositol 1,4,5-trisphosphate receptors: "exciting" players in cardiac excitation-contraction coupling?Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.Inositol 1,4,5-trisphosphate-mediated sarcoplasmic reticulum-mitochondrial crosstalk influences adenosine triphosphate production via mitochondrial Ca2+ uptake through the mitochondrial ryanodine receptor in cardiac myocytes.Nonalcoholic fatty liver disease impairs expression of the type II inositol 1,4,5-trisphosphate receptor.Activation of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis attenuates the cardiac reactivity to acute emotional stress.In utero exposure to diesel exhaust particulates is associated with an altered cardiac transcriptional response to transverse aortic constriction and altered DNA methylation.Type 2 inositol trisphosphate receptor gene expression in hepatocytes is regulated by cyclic AMP.Why a microRNA’s absence makes the heart grow larger.The Influence of MicroRNAs on Mitochondrial CalciummiR-133: A Suppressor of Cardiac Remodeling?MicroRNA-204 Is Necessary for Aldosterone-Stimulated T-Type Calcium Channel Expression in Cardiomyocytes
P2860
Q26995334-A06DD8B2-E068-4E55-9218-CA89486AD5DBQ34581173-C5A84E8E-D67B-4A82-8E1E-B98FC7201D9FQ34801354-D97EB2DE-7776-43E8-9E08-C6D45FE6301FQ34989031-E9929519-F14F-496A-B593-05DEDB9F7FCCQ35108100-C6364A7D-B423-4B7B-8B9A-B77264529A9AQ35733253-83BA36A4-7F1A-433E-A7C7-D9ACB7A31972Q35914331-2B3E67B2-9334-455B-A433-8AE8F5010ABEQ35940745-7A46C647-1F91-453D-9677-937964E1556EQ36224892-BD9BCCBF-2A2B-4465-8C4A-61A03F5F37EEQ36296735-857B3C9E-E427-479A-980C-B90159FAC41EQ36378208-8D3B0F78-C978-4FB3-A539-AD2BDB49FCC0Q37310442-49EC9640-2FFB-4385-A4AD-7004932B3BA5Q37544984-9F47F50F-A001-4B82-AA93-7212746CAE42Q37608568-00507360-C038-469A-A387-3152ED433C0AQ38142991-E0D1FCA5-F811-49D6-B5BD-A784BCA15EC0Q38265203-E2D52E7C-1723-4261-AB97-39D216F9875DQ38400171-4C7101D3-8EDD-4C98-BF24-7B6D09A9479BQ38686480-088804CF-DC3E-4987-B828-125E66E36486Q38885846-DC9E3DFA-E5B5-4BE7-AA86-9C6F959A8183Q38938135-B19A23FA-8B3E-4B68-8759-98B87C31A50BQ38988539-72F50A9A-B112-408B-B627-C7B0671DFE71Q39140608-46539EA5-86C5-4FBB-9C01-CC5F0BDC91CBQ40768860-6D966425-FDB2-4535-8406-8CAB7D7F984FQ41031513-79B74B41-AB0A-4D13-BB65-5A1286926885Q42275401-C8242D83-6B93-4905-B761-7C3988890EBCQ42750920-C770ECE5-1CEC-4B5D-BCBD-3A9D240945A1Q46297114-F305A396-8EFD-44A4-AE6B-CC0EC769CD11Q46505674-63DCD28A-C698-47BC-8F9D-2FCAB98BEA01Q47662853-83A50196-A5B8-4E5B-BAAD-19B6B4ED4626Q47965638-35C92A0F-5531-4A92-9D3B-DAEACAF1D667Q48019096-E6B30B2E-EBAA-409E-A7E2-EBE05C74B723Q51091264-38318620-5082-4E28-BBA7-BA5367EA03DFQ54996331-81E37D5D-752C-4682-B1A7-D446029919ECQ57300071-42C2A9AF-53A5-4BE5-82E7-CBAF3F6122E7Q58769694-94C4911A-0FD3-49AE-8E56-FF05CA20AEAFQ59138407-F26B1166-C219-48F8-8641-5352370F4F04
P2860
Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy
description
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
scientific journal article
@en
wetenschappelijk artikel (gepubliceerd op 2012/11/26)
@nl
wissenschaftlicher Artikel
@de
наукова стаття, опублікована в листопаді 2012
@uk
مقالة علمية (نشرت في 26-11-2012)
@ar
name
Mutual antagonism between IP(3 ...... ignals and cardiac hypertrophy
@ast
Mutual antagonism between IP(3 ...... ignals and cardiac hypertrophy
@en
type
label
Mutual antagonism between IP(3 ...... ignals and cardiac hypertrophy
@ast
Mutual antagonism between IP(3 ...... ignals and cardiac hypertrophy
@en
prefLabel
Mutual antagonism between IP(3 ...... ignals and cardiac hypertrophy
@ast
Mutual antagonism between IP(3 ...... ignals and cardiac hypertrophy
@en
P2093
P2860
P50
P356
P1476
Mutual antagonism between IP(3 ...... ignals and cardiac hypertrophy
@en
P2093
Dagmar Wachten
Faye M. Drawnel
Fredrik Swift
H. Llewelyn Roderick
Jeffery D. Molkentin
Katsuhiko Mikoshiba
Marjorie Maillet
Martin D. Bootman
Simon R. Andrews
P2860
P304
P356
10.1083/JCB.201111095
P407
P577
2012-11-26T00:00:00Z